Respiratory Devices Market Size & Growth Analysis – Share, Trends & Forecasts (2025 - 2030)

The Respiratory Devices Market is Segmented by Type (Diagnostic And Monitoring Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, Capnographs, And Other Diagnostic And Monitoring Devices), Therapeutic Devices (CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Oxygen Concentrators, Ventilators, Inhalers, and Other Therapeutic Devices), and Disposables (Masks, Breathing Circuits, and Other Disposables)), End Users (Hospitals, Respiratory Clinics, Other End Users) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). This Global Market Report Provides Value (in USD Billion) for the Above Segments.

Respiratory Devices Market Size & Growth Analysis – Share, Trends & Forecasts (2025 - 2030)

Respiratory Devices Market Size

Respiratory Devices Market Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 28.30 Billion
Market Size (2030) USD 37.68 Billion
CAGR (2025 - 2030) 5.89 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration High

Major Players

Respiratory Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Respiratory Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Respiratory Devices Market Analysis

The Global Respiratory Devices Market size is estimated at USD 28.30 billion in 2025, and is expected to reach USD 37.68 billion by 2030, at a CAGR of 5.89% during the forecast period (2025-2030).

Market statistics support the analysis that factors, including air pollution, occupational chemicals, childhood respiratory infections, tobacco smoking, and other environmental influences, are driving a rise in respiratory disorders like COPD, tuberculosis, asthma, and sleep apnea, globally. This surge in respiratory issues is set to propel the growth of the respiratory device market significantly.


Further, the global rise in tuberculosis (TB) cases is poised to boost the respiratory devices market growth in a notable manner. With TB cases surging worldwide, the demand for efficient diagnostic tools and treatment delivery systems has intensified. In regions with high TB infection rates, devices like nebulizers, inhalers, and diagnostic equipment play a pivotal role in managing the disease. For example, data released by the United States Department of Health & Human Services in March 2024 revealed that TB cases in the United States rose from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. Additionally, the incidence rate saw a jump from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Given this backdrop, the escalating TB burden underscores a growing demand for respiratory devices, diagnostics, and treatment solutions.


In addition, the high burden of respiratory diseases such as asthma is likely to contribute to the rising demand for respiratory diseases. For instance, the American Lung Association reported in July 2024 that in 2022, 44.2 million Americans were diagnosed with asthma, representing 13.5% of the population. Such statistics underscore the growing need for respiratory devices, fueling the market's expansion during the forecast period.


Additionally, according to a March 2024 article published in Cureus, smoking is a major risk factor for various non-communicable diseases, including lung cancer and chronic respiratory diseases. As tobacco use rises, so does the prevalence of chronic respiratory diseases, leading to heightened demand for respiratory treatment devices. The rising incidence of various respiratory diseases creates a demand for respiratory treatments, propelling the growth of respiratory devices industry over the forecast period.


Also, the launch and regulatory approval of advanced and sophisticated devices for respiratory diseases accentuates the market growth. For instance, in August 2024, Inspire Medical Systems secured FDA approval for its Inspire V neurostimulator therapy, designed for obstructive sleep apnea (OSA).


Consequently, driven by factors like the rising incidence of tuberculosis, asthma, and non-communicable diseases, the analyzed market of respiratory care devices and respiratory therapeutic devices is poised for growth during the forecast period. However, the high cost of devices is expected to hinder the market growth over the forecast period.

Respiratory Devices Industry Overview

The competitive landscape of the respiratory devices industry is semi-consolidated, with most players competing to maximize their market shares. Key players in the respiratory devices market research are Asahi Kasei Corporation (ZOLL Medical Corporation), Drive DeVilbiss Healthcare, Dragerwerk AG, Fisher & Paykel Healthcare Ltd., GE Healthcare, Getinge AB, GlaxoSmithKline PLC, Baxter International Inc., Invacare Corporation, Koninklijke Philips NV, Medtronic PLC, ResMed Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd among others.


These pivotal players emphasize technological advancements in their offerings, especially focusing on enhancing the market share and market value of their products. Such concentrated endeavors in market research are set to propel market growth in the foreseeable future.


For instance, in January 2023, OxyGo, renowned for its portable oxygen concentrators, has unveiled a comprehensive sleep line. This new lineup includes a CPAP, BPAP, essential PAP accessories, and a web-based adherence portal. The cloud provider portal offers secure web access for providers to efficiently manage and monitor patient data. Additionally, providers can seamlessly share this data and relevant statistics with physicians and other healthcare professionals. The portal is compatible with 1st-generation OxyGo CPAP and BPAP models through a card-to-cloud system and is set to connect with the newly launched 2nd-generation Wi-Fi models.


Consequently, strategic product launches by key companies are set to drive market growth and influence market trends during the forecast period.

Respiratory Devices Market Leaders

  1. DeVilbiss Healthcare LLC

  2. Dragerwerk AG

  3. Fisher & Paykel Healthcare Ltd

  4. GE Healthcare

  5. Getinge AB

  6. *Disclaimer: Major Players sorted in no particular order
Respiratory Devices Market Competitive Landscape
Need More Details on Market Players and Competiters?
Download PDF

Respiratory Devices Market News

  • October 2024: Finnish respiratory health innovator WellO2 unveiled its latest breathing exercise device at the Pharmacy Show 2024. Targeted at individuals pursuing drug-free methods to enhance respiratory function, WellO2 asserts that the device delivers validated advantages for those grappling with chronic issues such as asthma, sleep apnea, COPD, and other breathing challenges.
  • June 2024: Savara Inc., a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, held a conference to unveil the top-line results from the pivotal Phase 3 IMPALA-2 clinical trial. This trial evaluated the efficacy and safety of molgramostim, an inhaled variant of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), in patients suffering from aPAP.
  • June 2024: at the Med-Tech Innovation Expo, Aseptika unveiled the PUFFClicker3, a versatile smart inhaler dose tracker. This innovative device is designed to work seamlessly with both pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI).
  • May 2024: Medline unveiled the Hudson RCI TurboMist, its newest offering in the respiratory care portfolio. TurboMist, touted as the market's quickest small-volume nebulizer, administers medication treatments in just three minutes.

Respiratory Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Respiratory Disorders, Such as COPD, Tb, Asthma, and Sleep Apnea
    • 4.2.2 Technological Advancements and Increasing Applications In Homecare Setting
  • 4.3 Restraint
    • 4.3.1 High Cost of Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value in USD Billion)

  • 5.1 By Type
    • 5.1.1 Diagnostic and Monitoring Devices
    • 5.1.1.1 Spirometers
    • 5.1.1.2 Sleep Test Devices
    • 5.1.1.3 Peak Flow Meters
    • 5.1.1.4 Pulse Oximeters
    • 5.1.1.5 Capnographs
    • 5.1.1.6 Other Diagnostic and Monitoring Devices
    • 5.1.2 Therapeutic Devices
    • 5.1.2.1 Cpap Devices
    • 5.1.2.2 Bipap Devices
    • 5.1.2.3 Humidifiers
    • 5.1.2.4 Nebulizers
    • 5.1.2.5 Oxygen Concentrators
    • 5.1.2.6 Ventilators
    • 5.1.2.7 Inhalers
    • 5.1.2.8 Other Therapeutic Devices
    • 5.1.3 Disposables
    • 5.1.3.1 Masks
    • 5.1.3.2 Breathing Circuits
    • 5.1.3.3 Other Disposables
  • 5.2 By End Users
    • 5.2.1 Hospitals
    • 5.2.2 Respiratory Clinics
    • 5.2.3 Other End User
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Asahi Kasei Corporation (ZOLL Medical Corporation)
    • 6.1.2 Drive DeVilbiss Healthcare
    • 6.1.3 Dragerwerk AG
    • 6.1.4 Fisher & Paykel Healthcare Ltd.
    • 6.1.5 GE Healthcare
    • 6.1.6 Getinge AB
    • 6.1.7 GlaxoSmithKline PLC
    • 6.1.8 Baxter International Inc.
    • 6.1.9 Invacare Corporation
    • 6.1.10 Koninklijke Philips NV
    • 6.1.11 Medtronic PLC
    • 6.1.12 ResMed Inc.
    • 6.1.13 Shenzhen Mindray Bio-Medical Electronics Co. Ltd .
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Respiratory Devices Industry Segmentation

As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia.


The respiratory devices market is divided into type, end user and geography. By type, the market is segmented into diagnostic and monitoring devices, therapeutic devices, and disposables. By diagnostic and monitoring devices, the market is segmented into spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs, and other diagnostic and monitoring devices. By therapeutic devices, the market is segmented into CPAP devices, BiPAP devices, humidifiers, nebulizers, oxygen concentrators, ventilators, inhalers, and other therapeutic devices. By disposables, the market is segmented into masks, breathing circuits, and other disposables. By end user, the market is segmented into hospitals, respiratory clinics and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. The report offers the value (in USD Billion) for the above segments. By Type Diagnostic and Monitoring Devices Spirometers Sleep Test Devices Peak Flow Meters Pulse Oximeters Capnographs Other Diagnostic and Monitoring Devices Therapeutic Devices CPAP Devices BiPAP Devices Humidifiers Nebulizers Oxygen Concentrators Ventilators Inhalers Other Therapeutic Devices Disposables Masks Breathing Circuits Other Disposables By Geography North America United States Canada Mexico Europe Germany United Kingdom France Italy Spain Rest of Europe Asia Pacific China Japan India Australia South Korea Rest of Asia Pacific Middle East & Africa GCC South Africa Rest of Middle East & Africa South America Brazil Argentina Rest of South America

By Type Diagnostic and Monitoring Devices Spirometers
Sleep Test Devices
Peak Flow Meters
Pulse Oximeters
Capnographs
Other Diagnostic and Monitoring Devices
Therapeutic Devices Cpap Devices
Bipap Devices
Humidifiers
Nebulizers
Oxygen Concentrators
Ventilators
Inhalers
Other Therapeutic Devices
Disposables Masks
Breathing Circuits
Other Disposables
By End Users Hospitals
Respiratory Clinics
Other End User
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Respiratory Devices Market Research FAQs

How big is the respiratory care devices market?

The global respiratory care devices market size is estimated at USD 28.30 billion in 2025, and is expected to reach USD 37.68 billion by 2030, growing at a CAGR of 5.89% during the forecast period (2025-2030).

What factors are driving growth in the respiratory devices market?

Key market drivers encompass the growing prevalence of respiratory diseases, heightened demand for respiratory devices, and the introduction of technologically advanced products.

What are the different types of respiratory devices?

The different types of respiratory devices include diagnostic and monitoring devices, therapeutic devices, and disposables.

Who are the leading companies in the respiratory devices market?

Key companies in the market are GE Healthcare, Koninklijke Philips N.V., Medtronic PLC, and ResMed Inc., among others.

What are the most common respiratory conditions treated with these devices?

Inhalers and nebulizers play a crucial role in managing respiratory ailments, including asthma and COPD. By administering medication straight to the airways, inhalers offer swift relief during asthma episodes or moments of breathlessness.

Respiratory Care Devices Market Report Snapshots